These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21939669)

  • 1. Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction.
    Bahrudin U; Morikawa K; Takeuchi A; Kurata Y; Miake J; Mizuta E; Adachi K; Higaki K; Yamamoto Y; Shirayoshi Y; Yoshida A; Kato M; Yamamoto K; Nanba E; Morisaki H; Morisaki T; Matsuoka S; Ninomiya H; Hisatome I
    J Mol Biol; 2011 Nov; 413(4):857-78. PubMed ID: 21939669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
    Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
    J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of Hl-1 cardiac myocytes expressing E334k cMyBPC.
    Bahrudin U; Ikeda N; Utami SB; Maharani N; Morikawa K; Li P; Sobirin MA; Hasegawa A; Sakata S; Endo R; Rifqi S; Shirayoshi Y; Yamamoto K; Ninomiya H; Hisatome I
    Drug Res (Stuttg); 2013 Oct; 63(10):515-20. PubMed ID: 23740383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants.
    Sarikas A; Carrier L; Schenke C; Doll D; Flavigny J; Lindenberg KS; Eschenhagen T; Zolk O
    Cardiovasc Res; 2005 Apr; 66(1):33-44. PubMed ID: 15769446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol Suppresses Apoptosis and Ion Channel Remodelling of HL-1 Cardiac Myocytes Expressing E334K cMyBPC.
    Endo R; Bahrudin U; Notsu T; Tanno S; Onohara T; Yamaguchi S; Ikeda N; Surastri B; Nakayama Y; Ninomiya H; Shirayoshi Y; Inagaki Y; Yamamoto K; Yoshida A; Hisatome I
    Drug Res (Stuttg); 2016 Mar; 66(3):126-9. PubMed ID: 26479129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy.
    Schlossarek S; Englmann DR; Sultan KR; Sauer M; Eschenhagen T; Carrier L
    Basic Res Cardiol; 2012 Jan; 107(1):235. PubMed ID: 22189562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities.
    Schlossarek S; Mearini G; Carrier L
    J Mol Cell Cardiol; 2011 Apr; 50(4):613-20. PubMed ID: 21291890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HCM-causing Y235S cMyBPC mutation accelerates contractile function by altering C1 domain structure.
    Doh CY; Li J; Mamidi R; Stelzer JE
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):661-677. PubMed ID: 30611859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice.
    Tsukamoto O; Minamino T; Okada K; Shintani Y; Takashima S; Kato H; Liao Y; Okazaki H; Asai M; Hirata A; Fujita M; Asano Y; Yamazaki S; Asanuma H; Hori M; Kitakaze M
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1125-33. PubMed ID: 16403436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin-proteasome system may be involved in the pathogenesis of hypertrophic cardiomyopathy.
    Vosberg HP
    Cardiovasc Res; 2005 Apr; 66(1):1-3. PubMed ID: 15769440
    [No Abstract]   [Full Text] [Related]  

  • 11. Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction.
    Mouton J; Loos B; Moolman-Smook JC; Kinnear CJ
    Exp Cell Res; 2015 Feb; 331(2):338-51. PubMed ID: 25449695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stressing the ubiquitin-proteasome system.
    Dantuma NP; Lindsten K
    Cardiovasc Res; 2010 Jan; 85(2):263-71. PubMed ID: 19633314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.
    Menéndez-Benito V; Verhoef LG; Masucci MG; Dantuma NP
    Hum Mol Genet; 2005 Oct; 14(19):2787-99. PubMed ID: 16103128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bepridil Suppresses Apoptosis in HL-1 Cardiac Atrial Myocytes Expressing Mutant E334K cMyBPC.
    Endo R; Notsu T; Mishima M; Morikawa K; Li P; Ikeda N; Ninomiya H; Shirayoshi Y; Hisatome I
    Yonago Acta Med; 2013 Dec; 56(4):93-5. PubMed ID: 24574578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Into the heart: the emerging role of the ubiquitin-proteasome system.
    Willis MS; Patterson C
    J Mol Cell Cardiol; 2006 Oct; 41(4):567-79. PubMed ID: 16949602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.
    Thottakara T; Friedrich FW; Reischmann S; Braumann S; Schlossarek S; Krämer E; Juhr D; Schlüter H; van der Velden J; Münch J; Patten M; Eschenhagen T; Moog-Lutz C; Carrier L
    J Mol Cell Cardiol; 2015 Oct; 87():214-24. PubMed ID: 26343497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling.
    Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J
    J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome system: focus on the heart.
    Zolk O; Schenke C; Sarikas A
    Cardiovasc Res; 2006 Jun; 70(3):410-21. PubMed ID: 16497285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations.
    Moolman-Smook J; Flashman E; de Lange W; Li Z; Corfield V; Redwood C; Watkins H
    Circ Res; 2002 Oct; 91(8):704-11. PubMed ID: 12386147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.